{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T15:10:18Z","timestamp":1734102618321,"version":"3.30.2"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","americanjournalofsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.amjsurg.2024.116020","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T20:00:32Z","timestamp":1729368032000},"page":"116020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fragility index for extended prophylaxis following abdominopelvic surgery: A methodological survey"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-4096","authenticated-orcid":false,"given":"Tyler","family":"McKechnie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruxandra-Maria","family":"Bogdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2102-1498","authenticated-orcid":false,"given":"Victoria","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagla","family":"Eskicioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameer","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjsurg.2024.116020_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0146-0005(97)80013-4","article-title":"Evidence-based medicine","volume":"21","author":"Sackett","year":"1997","journal-title":"Semin Perinatol"},{"issue":"7126","key":"10.1016\/j.amjsurg.2024.116020_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/bmj.316.7126.201","article-title":"Understanding controlled trials. Why are randomised controlled trials important?","volume":"316","author":"Sibbald","year":"1998","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.amjsurg.2024.116020_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ebmed-2016-110401","article-title":"New evidence pyramid","volume":"21","author":"Murad","year":"2016","journal-title":"Evid Base Med"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.seminhematol.2008.04.003","article-title":"A\u00a0dirty dozen: twelve P-value misconceptions","volume":"45","author":"Goodman","year":"2008","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA's statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Statistician"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.116020_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index","volume":"67","author":"Walsh","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.amjsurg.2024.116020_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/2192568220941684","article-title":"How fragile are the results of a trial? The fragility index","volume":"10","author":"Dettori","year":"2020","journal-title":"Global Spine J"},{"issue":"10","key":"10.1016\/j.amjsurg.2024.116020_bib8","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.spinee.2015.06.004","article-title":"The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey","volume":"15","author":"Evaniew","year":"2015","journal-title":"Spine J"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/DCR.0000000000002146","article-title":"When the p value doesn't cut it: the fragility index applied to randomized controlled trials in colorectal surgery","volume":"65","author":"Nelms","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2024.116020_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-023-01298-1","article-title":"Fragility of statistically significant outcomes in randomized trials comparing bariatric surgeries","author":"Lee","year":"2023","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib11","first-page":"414","article-title":"Fragility of statistically significant outcomes in colonic diverticular disease randomized trials: a systematic review","volume":"67","author":"McKechnie","year":"2024","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.116020_bib12","article-title":"Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study","volume":"8","author":"Kakkar","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"13","key":"10.1016\/j.amjsurg.2024.116020_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.amjsurg.2024.116020_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SLA.0000000000000340","article-title":"A\u00a0randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"259","author":"Vedovati","year":"2014","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jso.26728","article-title":"Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: a multidisciplinary quality improvement project","volume":"125","author":"McGinnis","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib16","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.amjsurg.2024.116020_bib17","first-page":"1162","article-title":"The American society of colon and rectal Surgeons clinical practice guidelines for the reduction of venous thromboembolic disease in colorectal surgery","volume":"66","author":"Patel","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2024.116020_bib18","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.amjsurg.2024.116020_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s00464-023-10063-4","article-title":"Fragility of statistically significant findings from randomized trials in comparing laparoscopic versus robotic abdominopelvic surgeries","author":"Lee","year":"2023","journal-title":"Surg Endosc"},{"issue":"12","key":"10.1016\/j.amjsurg.2024.116020_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005755","article-title":"Fragility index in cardiovascular randomized controlled trials","volume":"12","author":"Khan","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjsurg.2024.116020_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","article-title":"Revised Cochrane risk-of-bias tool for randomized trials (RoB 2)","author":"Higgins","year":"2019","journal-title":"Cochrane Handb Syst Rev Interve"},{"issue":"9","key":"10.1016\/j.amjsurg.2024.116020_bib24","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1177\/0363546516674469","article-title":"The fragility of statistically significant findings from randomized trials in sports surgery: a systematic survey","volume":"45","author":"Khan","year":"2017","journal-title":"Am J Sports Med"},{"issue":"11","key":"10.1016\/j.amjsurg.2024.116020_bib25","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1538-7836.2006.02153.x","article-title":"Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study","volume":"4","author":"Rasmussen","year":"2006","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"8","key":"10.1016\/j.amjsurg.2024.116020_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.2022015796","article-title":"Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer","volume":"140","author":"Becattini","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib27","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.thromres.2009.09.009","article-title":"Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study","volume":"125","author":"Sakon","year":"2010","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2020.05.001","article-title":"Effect of pharmacologic prophylaxis on venous thromboembolism after radical prostatectomy: the PREVENTER randomized clinical trial","volume":"78","author":"Patel","year":"2020","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.amjsurg.2024.116020_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/110241598750005534","article-title":"Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis","volume":"164","author":"Lausen","year":"2003","journal-title":"Eur J Surg"},{"issue":"9","key":"10.1016\/j.amjsurg.2024.116020_bib30","doi-asserted-by":"crossref","first-page":"387.e7","DOI":"10.1016\/j.urolonc.2014.12.010","article-title":"Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery","volume":"33","author":"Kukreja","year":"2015","journal-title":"Urol Oncol: Semin Origin Invest"},{"issue":"8","key":"10.1016\/j.amjsurg.2024.116020_bib31","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1464-410X.2010.09639.x","article-title":"Extended venous thromboembolism prophylaxis after radical pelvic surgery for urological cancers","volume":"106","author":"Phillips","year":"2010","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2008-1066550","article-title":"Thromboembolism prophylaxis with low molecular weight heparin in abdominal surgery","volume":"114","author":"Adolf","year":"1989","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"10.1016\/j.amjsurg.2024.116020_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1365-2168.1999.0701c.x","article-title":"Vascular surgical society of great britain and Ireland: randomized controlled trial of heparin plus graduated compression stocking for the prophylaxis of deep venous thrombosis in general surgical patients","volume":"86","author":"Perkins","year":"1999","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00000658-200103000-00020","article-title":"Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery","volume":"233","author":"McLeod","year":"2001","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.amjsurg.2024.116020_bib35","first-page":"455","article-title":"Defibrotide versus heparin in antithrombotic prophylaxis in gynecological surgery","volume":"80","author":"Lippi","year":"1989","journal-title":"Minerva Med"},{"issue":"Suppl 2","key":"10.1016\/j.amjsurg.2024.116020_bib36","first-page":"11","article-title":"Prospective double-blind comparison between Fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications","volume":"16","author":"Bergqvist","year":"1986","journal-title":"Haemostasis"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib37","first-page":"156","article-title":"Thromboprophylaxis with a low molecular weight heparin (tinzaparin) in emergency abdominal surgery. A double-blind multicenter trial","volume":"25","author":"Bergqvist","year":"1996","journal-title":"Vasa"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib38","first-page":"553","volume":"158","author":"Pitts","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.amjsurg.2024.116020_bib39","doi-asserted-by":"crossref","unstructured":"Auer RC, Ott M, Karanicolas P, et\u00a0al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. Published online September 13, 2022:e071375. doi:10.1136\/bmj-2022-071375.","DOI":"10.1136\/bmj-2022-071375"},{"issue":"23","key":"10.1016\/j.amjsurg.2024.116020_bib40","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.amjsurg.2024.116020_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.116020_bib42","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/jth.13687","article-title":"A\u00a0decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients","volume":"15","author":"Le","year":"2017","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.amjsurg.2024.116020_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110148","article-title":"Applying the fragility index to randomized controlled trials evaluating total neoadjuvant therapy for rectal cancer: a methodological survey","volume":"194","author":"McKechnie","year":"2024","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2024.116020_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41366-023-01298-1","article-title":"Fragility of statistically significant outcomes in randomized trials comparing bariatric surgeries","volume":"47","author":"Lee","year":"2023","journal-title":"Int J Obes"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.116020_bib45","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00464-023-10063-4","article-title":"Fragility of statistically significant findings from randomized trials in comparing laparoscopic versus robotic abdominopelvic surgeries","volume":"37","author":"Lee","year":"2023","journal-title":"Surg Endosc"},{"issue":"5","key":"10.1016\/j.amjsurg.2024.116020_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.amjsurg.2024.116020_bib47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.116020_bib48","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","article-title":"Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses","volume":"98","author":"Ioannidis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.amjsurg.2024.116020_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis\u2014a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.amjsurg.2024.116020_bib50","doi-asserted-by":"crossref","unstructured":"Felder S, Rasmussen MS, King R, et\u00a0al. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. Published online November 27, 2018. doi:10.1002\/14651858.CD004318.pub3.","DOI":"10.1002\/14651858.CD004318.pub3"},{"key":"10.1016\/j.amjsurg.2024.116020_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2023.101111","article-title":"Statistical fragility of venous thromboembolism prophylaxis following total joint arthroplasty","volume":"20","author":"Sequeira","year":"2023","journal-title":"Arthroplast Today"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.116020_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/jth.14362","article-title":"Recommendations on thromboprophylaxis in major joint arthroplasty \u2013 many guidelines, little consensus?","volume":"17","author":"J\u00f8rgensen","year":"2019","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.amjsurg.2024.116020_bib54","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/2192568220941684","article-title":"How fragile are the results of a trial? The fragility index","volume":"10","author":"Dettori","year":"2020","journal-title":"Global Spine J"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024005725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024005725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T14:49:37Z","timestamp":1734101377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961024005725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0002961024005725"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.116020","relation":{},"ISSN":["0002-9610"],"issn-type":[{"type":"print","value":"0002-9610"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fragility index for extended prophylaxis following abdominopelvic surgery: A methodological survey","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.116020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116020"}}